VERO
Venus Concept Inc
$
2.440
- Overview
- Forecast
- Valuation
- Earnings
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
2.565
Open
2.540
VWAP
--
Vol
30.48K
Mkt Cap
4.54M
Low
2.440
Amount
--
EV/EBITDA(TTM)
--
Total Shares
6.36M
EV
37.28M
EV/OCF(TTM)
--
P/S(TTM)
0.03
Venus Concept Inc. is a global medical technology company. The Company develops, commercializes and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services and reaches over 60 countries and nine direct markets. The Company’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Versa Pro, Venus Legacy, Venus Velocity, Venus Viva, Venus Glow, Venus Bliss, Venus Bliss MAX, Venus Epileve, Venus Viva MD and AI.ME. Its treatments for hair loss are divided into non-surgical options and surgical procedures. Its hair restoration systems include NeoGraft and the ARTAS iX Robotic Hair Restoration system. Its systems are designed on flexible platforms that enable it to expand beyond the aesthetic industry’s traditional markets of dermatology and plastic surgery, and into non-traditional markets, including family medicine and general practitioners and aesthetic medical spas.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q2
FY2025Q3
FY2025Q4
14.01M
-15.5%
--
--
14.48M
-3.5%
--
--
16.00M
+1.5%
--
--
Estimates Revision
The market is revising No Change the revenue expectations for Venus Concept Inc. (VERO) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by 0.41%.
Revenue Estimates for FY2025
No Change
0.00%
In Past 3 Month
Stock Price
Go Up
+0.41%
In Past 3 Month
1 Analyst Rating
2.46% Upside
Wall Street analysts forecast VERO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for VERO is 2.50 USD with a low forecast of 2.50 USD and a high forecast of 2.50 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
1 Hold
0 Sell
Hold
2.46% Upside
Current: 2.440
Low
2.50
Averages
2.50
High
2.50
2.46% Upside
Current: 2.440
Low
2.50
Averages
2.50
High
2.50
The End
See All Ratings
No Data
Valuation Metrics
The current forward P/E ratio for Venus Concept Inc (VERO.O) is -0.15, compared to its 5-year average forward P/E of -2.00. For a more detailed relative valuation and DCF analysis to assess Venus Concept Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
-2.00
Current PE
-0.15
Overvalued PE
0.25
Undervalued PE
-4.26
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
-14.50
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
2.85
Undervalued EV/EBITDA
-31.86
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
Fair
5Y Average PS
0.45
Current PS
0.08
Overvalued PS
0.89
Undervalued PS
0.00
Financials
Annual
Quarterly
FY2025Q1
YoY :
-21.95%
13.64M
Total Revenue
FY2025Q1
YoY :
+38.70%
-9.50M
Operating Profit
FY2025Q1
YoY :
+26.33%
-12.37M
Net Income after Tax
FY2025Q1
YoY :
-5.63%
-17.44
EPS - Diluted
FY2025Q1
YoY :
+118.57%
-6.35M
Free Cash Flow
FY2025Q1
YoY :
-3.69%
64.17
Gross Profit Margin - %
FY2025Q1
YoY :
+77.31%
-23.99
FCF Margin - %
FY2025Q1
YoY :
+61.86%
-90.64
Net Margin - %
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
13.2K
USD
1
0-12
Months
179.6K
USD
3
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
13.2K
USD
1
0-12
Months
179.6K
USD
3
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
VERO News & Events
Events Timeline
2025-06-20 (ET)
2025-06-20
17:29:07
Venus Concept files to sell 900K shares of common stock for holders
2025-06-06 (ET)
2025-06-06
11:37:28
Venus Concept announces $3.45M registered direct offering
2025-06-06
07:32:04
Venus Concept to sell Venus Hair business for $20M
Sign Up For More Events
Sign Up For More Events
News
9.5
07-16NewsfilterVenus Concept to Release Second Quarter of Fiscal Year 2025 Financial Results on August 14, 2025
8.5
07-01NewsfilterVenus Concept Announces $6.5 Million Debt-to-Equity Exchange Transaction
2.0
06-30BenzingaWhy Venus Concept Shares Are Trading Higher By Over 32%; Here Are 20 Stocks Moving Premarket
Sign Up For More News
People Also Watch
ATCH
Atlasclear Holdings Inc
0.169
USD
-5.59%
CNEY
CN Energy Group Inc
2.480
USD
-1.98%
DWTX
Dogwood Therapeutics Inc
4.800
USD
-0.41%
DGLY
Digital Ally Inc
1.985
USD
+0.25%
ENTO
Entero Therapeutics Inc
0.471
USD
0.00%
BBLG
Bone Biologics Corp
2.670
USD
-10.70%
WINT
Windtree Therapeutics Inc
0.815
USD
-11.41%
BDRX
Biodexa Pharmaceuticals PLC
0.860
USD
-2.27%
FAQ
What is Venus Concept Inc (VERO) stock price today?
The current price of VERO is 2.44 USD — it has decreased -3.94 % in the last trading day.
What is Venus Concept Inc (VERO)'s business?
What is the price predicton of VERO Stock?
What is Venus Concept Inc (VERO)'s revenue for the last quarter?
What is Venus Concept Inc (VERO)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Venus Concept Inc (VERO)'s fundamentals?
How many employees does Venus Concept Inc (VERO). have?